Laurie Toich, Assistant Editor

A majority of specialty physicians have knowledge gaps when it comes to biosimilars.

The FDA recently approved 2 Teva Pharmaceutical generic drugs for use in patients with hypertension.

Physicians may lack knowledge about fundamental information regarding biosimilars.

The New Drug Application for pharmaceutical grade L-glutamine was accepted because of positive results from a clinical trial.

Beneficial results seen when switching to a HIV regimen including Odefsey.

Beneficial results seen when switching to a HIV regimen including Odefsey.

Exposing dendritic cells and introducing them into mice nearly eliminated anaphylactic responses.

Levels of fatty acid amide hydrolase could be involved in treating cannabis use disorder.

Clinicians will now have more opportunities to earn the incentive payment.

Top news of the day from across the healthcare landscape.

A new survey reveals patients are concerned about costs, but largely unaware of health plan benefits.

Having multiple sclerosis may not increase the risk of breast cancer in women.

Patients taking baricitinib saw improvements in rheumatoid arthritis symptoms as soon as a week into treatment.

Immunizing mouse models with Qa-1 derived from myelin prevented multiple sclerosis disease progression.

Data plays an increasingly important role in improving health care services.

SPK-9001 increased quality of life in nearly all study participants with hemophilia B.

Niemann-Pick disease could be treated with gene therapy.

Total thyroidectomy is the most common treatment for thyroid cancer.

Top news of the day from across the healthcare landscape.

While out-of-pocket spending is decreasing, many are spending over $1000 per year on prescription drugs.

Enbrel is now indicated in pediatric patients with moderate-to-severe plaque psoriasis.

Phase 2 studies of GS-4997 presented successful results in patients with non-alcoholic steatohepatitis.

Treatment with ozanimod associated with decreased partial Mayo scores in inflammatory bowel disease.

Nearly half of patients on epicutaneous immunotherapy achieved treatment success.

HIV positive patients coinfected with hepatitis may face elevated cancer risk.

Only 13% of patients taking opioids for low back pain said the treatment was very successful.

Vaxchora is the first approved vaccine for protection against cholera.

Top news of the day from across the healthcare landscape.

Novartis wins Prix Galien Awards for Cosentyx and Gleevec.

Developed countries may be able to assist developing countries in ensuring their drugs are safe.